Quick Takeaways
- BROADWOOD PARTNERS, L.P. filed SCHEDULE 13D/A for Insight Molecular Diagnostics Inc. Common Stock, no par value (IMDX).
- Disclosed ownership: 40%.
- Date of event: 23 Apr 2026.
BROADWOOD PARTNERS, L.P. - 23 Apr 2026 SCHEDULE 13D/A Report for Insight Molecular Diagnostics Inc. Common Stock, no par value (IMDX)
- Filing Manager
- BROADWOOD PARTNERS, L.P.
- Reporting Manager
- Neal C. Bradsher
- Symbol
- IMDX
- Shares outstanding
- 32,330,312 shares
- Disclosed Ownership
- 12,835,134 shares
- Ownership
- 40%
- Form type
- SCHEDULE 13D/A
- Filing time
- 27 Apr 2026, 19:14:08 UTC
- Date of event
- 23 Apr 2026
- Previous filing
- 12 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"BROADWOOD PARTNERS, L.P. disclosed 40% ownership in Insight Molecular Diagnostics Inc. Common Stock, no par value (IMDX) on 23 Apr 2026."
What Changed
- Previous schedule filing date: 12 Feb 2026.
- Current filing was accepted on 27 Apr 2026, 19:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Broadwood Partners, L.P. | 40% | 12,834,977 | 0 | 12,834,977 | /s/ Neal C. Bradsher* | Neal C. Bradsher/President of Broadwood Capital Inc. | 0001278386 |
| Broadwood Capital, Inc. | 40% | 12,834,977 | 0 | 12,834,977 | /s/ Neal C. Bradsher* | Neal C. Bradsher/President | 0001278387 |
| Neal C. Bradsher | 40% | 12,835,134 | 157 | 12,834,977 | /s/ Neal C. Bradsher* | Neal C. Bradsher | 0001278388 |